Charles River Laboratories Intl. Inc vs HCA Health Inc — how do they compare? Charles River Laboratories Intl. Inc trades at $282 (market cap $13.46B), while HCA Health Inc trades at $411 (market cap $89.08B). The key difference: HCA Health Inc is far larger — about 6.6× Charles River Laboratories Intl. Inc's market cap, and HCA Health Inc pays a 0.76% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals.
| CRL | HCA | |
|---|---|---|
Market Cap | $13.46B | $89.08B |
Sector | Health | Health |
52-Week High | $282.00 | $545.13 |
52-Week Low | $145.57 | $361.32 |
Enterprise Value | $16.30B | $139.62B |
Dividend Yield | — | 0.76% |
Trailing returns across standard periods
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →